DuPont Nutrition & Health (N&H) has received approval from the European Commission (EC) to divest its heritage DuPont N&H Alginates business to JRS Group, a leading manufacturer of functional additives from plant-based raw materials. The divestiture is expected to close in Q3 2018.
The transaction with JRS Group includes the heritage DuPont N&H Alginates business, comprising pure and buffered alginates, a specific portfolio of pectin-alginate blends, the associated Landerneau production site and customer relationships.
The divestiture was a requirement set out by the EC upon its conditional approval of DuPont’s acquisition of FMC’s Health & Nutrition (H&N) business in 2017.
“The receipt of regulatory approval to divest the heritage DuPont N&H Alginates business is an important step in finalizing our integration of FMC’s Health & Nutrition Business. Our team is dedicated to creating value for our customers through the integration of our new DuPont N&H product portfolio, which combines the heritage portfolios of DuPont N&H, FMC H&N and Dow Food & Pharma to deliver a unique offering in the food ingredients and pharma excipients market,” said DuPont N&H Business President Matthias Heinzel.
DuPont N&H will continue to be active in the alginates market after the transaction closes through the FMC H&N alginates portfolio. DuPont N&H is one of the world’s leading specialty ingredients companies delivering unmatched value to the food, beverage, pharmaceutical and dietary supplements industries.